• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND DIAGNOSTICS DIVISION ALINITY I STAT HIGH SENSITIVITY TROPONIN-I; IMMUNOASSAY METHOD, TROPONIN SUBUNIT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND DIAGNOSTICS DIVISION ALINITY I STAT HIGH SENSITIVITY TROPONIN-I; IMMUNOASSAY METHOD, TROPONIN SUBUNIT Back to Search Results
Catalog Number 04Z21-35
Medical Device Problem Code High Test Results (2457)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 12/05/2025
Type of Reportable Event Malfunction
Event or Problem Description
The customer observed a falsely elevated alinity i stat high sensitive troponin-i result for one 34 year old female patient with chest pain that was admitted for observation due to the chest pain.The sample and other samples were then ran with lower results.The following data was provided: sid (b)(6) processed on (b)(6) 2025 at 10:26 am = 161 ng/l this sample repeated after centrifuging on (b)(6) 2025 result = 3 ng/l.The patient was drawn two other times after initial result with both sample results = 3 ng/l.Customer¿s troponin reference range <15 females no impact to patient management was reported.
 
Additional Manufacturer Narrative
An evaluation is in process.A final report will be submitted when the evaluation is complete.All available patient information was included.Additional patient details are not available.
 
Event or Problem Description
The customer observed a falsely elevated alinity i stat high sensitive troponin-i result for one 34-year-old female patient with chest pain that was admitted for observation due to the chest pain.The sample and other samples were then ran with lower results.The following data was provided: sid (b)(6), processed on (b)(6) 2025 at 10:26 am = 161 ng/l this sample repeated after centrifuging on (b)(6) 2025 result = 3 ng/l.The patient was drawn two other times after initial result with both sample results = 3 ng/l customer¿s troponin reference range <15 females no impact to patient management was reported.
 
Additional Manufacturer Narrative
The data and information provided by the customer were reviewed and support the complaint issue without indication for any additional issue.A search for similar complaints did not identify an increase in complaint activity for lot 79025ud00.A review of tracking and trending for the alinity i stat high sensitivity troponin-i assay did not identify any related trends.The device history review did not identify any nonconformances, potential nonconformance or deviations associated with lot 79025ud00 and the complaint issue.Accuracy testing was completed using panels which mimic patient samples and an in-house retained kit of lot 79024ud00 (which contains the same bulk material as lot 79025ud00).All specifications were met, indicating that the lot is performing acceptably.Labeling was reviewed and sufficiently addresses the customer¿s issue.A malfunction was not identified.Based on the information within the complaint record, the device met performance specifications and performed as intended at the customer site.In this case, a use error occurred as the sample was refrigerated between tests.As per labelling, plasma should be stored at room temperature (15¿30°c) for a maximum of 8 hours.Based on the investigation, no systemic issue or deficiency of the alinity i stat high sensitivity troponin-i, lot number 79025ud00, was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALINITY I STAT HIGH SENSITIVITY TROPONIN-I
Common Device Name
IMMUNOASSAY METHOD, TROPONIN SUBUNIT
Manufacturer (Section D)
ABBOTT IRELAND DIAGNOSTICS DIVISION
lisnamuck
co. longford
longford N39E9 32
EI  N39E932
Manufacturer (Section G)
ABBOTT IRELAND DIAGNOSTICS DIVISION
lisnamuck
co. longford
longford N39E9 32
EI   N39E932
Manufacturer Contact
nicole jenne
max-planck-ring 2
post market surveillance
wiesbaden 65205
GM   65205
6122582960
MDR Report Key23879433
Report Number3005094123-2025-00659
Device Sequence Number11938812
Product Code MMI
UDI-Device Identifier00380740194079
UDI-Public(01)00380740194079(17)260128(10)79025UD00
Combination Product (Y/N)N
Initial Reporter StateOK
Initial Reporter CountryUS
PMA/510(K) Number
K202525
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 03/04/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date01/28/2026
Device Catalogue Number04Z21-35
Device Lot Number79025UD00
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 12/09/2025
Supplement Date Received by Manufacturer02/24/2026
Initial Report FDA Received Date12/23/2025
Supplement Report FDA Received Date03/04/2026
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured08/11/2025
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
ALNTY I PROCESSING MODU, 03R65-01, (B)(6) ; ALNTY I PROCESSING MODU, 03R65-01, (B)(6)
Patient Age34 YR
Patient SexFemale
-
-